{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:57:00Z","timestamp":1765807020688},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00105-011-2228-4","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T09:23:40Z","timestamp":1330507420000},"page":"184-191","source":"Crossref","is-referenced-by-count":7,"title":["\u201eStiefkind\u201c Nagelpsoriasis"],"prefix":"10.1007","volume":"63","author":[{"given":"C.","family":"Kahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"key":"2228_CR1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000119415","volume":"216","author":"Augustin","year":"2008","unstructured":"Augustin M, Kr\u00fcger K, Radtke MA et al (2008) Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 216(4):366\u2013372","journal-title":"Dermatology"},{"key":"2228_CR2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","volume":"163","author":"Augustin","year":"2010","unstructured":"Augustin M, Reich K, Blome C et al (2010) Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 163(3):580\u2013585","journal-title":"Br J Dermatol"},{"key":"2228_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316169","volume":"221","author":"Baran","year":"2010","unstructured":"Baran R (2010) The burden of nail psoriasis: an introduction. Dermatology 221(Suppl 1):1\u20135","journal-title":"Dermatology"},{"key":"2228_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1998.02031.x","volume":"138","author":"De","year":"1998","unstructured":"De Berker DA, Lawrence CM (1998) A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 138(1):90\u201395","journal-title":"Br J Dermatol"},{"key":"2228_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","volume":"193","author":"De","year":"1996","unstructured":"De Jong EM, Seegers BA, Gulinck MK et al (1996) Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 193(4):300\u2013303","journal-title":"Dermatology"},{"key":"2228_CR6","first-page":"1417","volume":"69","author":"Fawcett","year":"2004","unstructured":"Fawcett RS, Linford S, Stulberg DL (2004) Nail abnormalities: clues to systemic disease. Am Fam Physician 69(6):1417\u20131424","journal-title":"Am Fam Physician"},{"key":"2228_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ard.2007.075101","volume":"67","author":"Gisondi","year":"2008","unstructured":"Gisondi P, Tinazzi I, El-Dalati G et al (2008) Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 67(1):26\u201330","journal-title":"Ann Rheum Dis"},{"key":"2228_CR8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/17469872.3.3.339","volume":"3","author":"Gregoriou","year":"2008","unstructured":"Gregoriou S, Kalogeromitros D, Kosionis N et al (2008) Treatment options for nail psoriasis. Expert Rev Dermatol 3:339\u2013344","journal-title":"Expert Rev Dermatol"},{"key":"2228_CR9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","volume":"25","author":"G\u00fcm\u00fc\u015fel","year":"2011","unstructured":"G\u00fcm\u00fc\u015fel M, \u00d6zdemir M, Mevlito\u011flu I, Bodur S (2011) Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. J Eur Acad Dermatol Venereol 25(9):1080\u20131084","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2228_CR10","doi-asserted-by":"crossref","unstructured":"Hamm H (2005) Erkrankungen der N\u00e4gel. In: Braun-Falco O, Plewig G, Wolff HH et al (Hrsg) Dermatologie und Venerologie. Springer, Berlin, S\u00a0955","DOI":"10.1007\/3-540-26624-0_64"},{"key":"2228_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","volume":"57","author":"Jiaravuthisan","year":"2007","unstructured":"Jiaravuthisan MM, Sasseville D, Vender RB et al (2007) Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 57(1):1\u201327","journal-title":"J Am Acad Dermatol"},{"key":"2228_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1529-8019.2007.00112.x","volume":"20","author":"Lawry","year":"2007","unstructured":"Lawry M (2007) Biologic therapy and nail psoriasis. Dermatol Ther 20(1):60\u201367","journal-title":"Dermatol Ther"},{"key":"2228_CR13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","volume":"23","author":"Luger","year":"2009","unstructured":"Luger TA, Barker J, Lambert J et al (2009) Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol 23(8):896\u2013904","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2228_CR14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/09546630902787585","volume":"20","author":"M\u00e1rquez","year":"2009","unstructured":"M\u00e1rquez Balb\u00e1s G, S\u00e1nchez Rega\u00f1a M, Umbert Millet P (2009) Tacalcitol ointment for the treatment of nail psoriasis. J Dermatolog Treat 20(5):308\u2013310","journal-title":"J Dermatolog Treat"},{"key":"2228_CR15","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"McGonagle","year":"2007","unstructured":"McGonagle D, Lories RJ, Tan AL, Benjamin M (2007) The concept of a \u201esynovio-entheseal complex\u201c and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 56(8):2482\u20132491","journal-title":"Arthritis Rheum"},{"key":"2228_CR16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/art.10841","volume":"48","author":"McGonagle","year":"2003","unstructured":"McGonagle D, Marzo-Ortega H, Benjamin M, Emery P (2003) Report on the Second international Enthesitis Workshop. Arthritis Rheum 48(4):896\u2013905","journal-title":"Arthritis Rheum"},{"key":"2228_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000316171","volume":"221","author":"McGonagle","year":"2010","unstructured":"McGonagle D, Palmou Fontana N, Tan AL, Benjamin M (2010) Nailing down the genetic and immunological basis for psoriatic disease. Dermatology 221(Suppl 1):15\u201322","journal-title":"Dermatology"},{"key":"2228_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"Mrowietz","year":"2011","unstructured":"Mrowietz U, Kragballe K, Reich K et al (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303(1):1\u201310","journal-title":"Arch Dermatol Res"},{"key":"2228_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1524-4725.2009.01448.x","volume":"36","author":"Oram","year":"2010","unstructured":"Oram Y, Karincao\u011flu Y, Koyuncu E, Kaharaman F (2010) Pulsed dye laser in the treatment of nail psoriasis. Dermatol Surg 36(3):377\u2013381","journal-title":"Dermatol Surg"},{"key":"2228_CR20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2009.03344.x","volume":"24","author":"Ortonne","year":"2010","unstructured":"Ortonne JP, Baran R, Corvest M et al (2010) Development and validation of nail psoriasis quality of life scale (NPQ10). J Eur Acad Dermatol Venereol 24(1):22\u201327","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2228_CR21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2353\/ajpath.2008.070710","volume":"172","author":"Raychaudhuri","year":"2008","unstructured":"Raychaudhuri SP, Jiang WY, Raychaudhuri SK (2008) Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol 172(4):961\u2013971","journal-title":"Am J Pathol"},{"key":"2228_CR22","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","volume":"160","author":"Reich","year":"2009","unstructured":"Reich K, Kr\u00fcger K, M\u00f6ssner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160(5):1040\u20131047","journal-title":"Br J Dermatol"},{"key":"2228_CR23","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1010858","volume":"365","author":"Reich","year":"2011","unstructured":"Reich K, Langley RG, Papp KA et al (2011) A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis. N Engl J Med 365(17):1586\u20131596","journal-title":"N Engl J Med"},{"key":"2228_CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","volume":"58","author":"Rich","year":"2008","unstructured":"Rich P, Griffiths CE, Reich K et al (2008) Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 58(2):224\u2013231","journal-title":"J Am Acad Dermatol"},{"key":"2228_CR25","unstructured":"Rich P et al (2008) Improvement in nail psoriasis with ustekinumab, a new anti-IL-12\/23 P40 monoclonal antibody: results from a phase 3 trial (PHOENIX 1). EADV Abstract FP1007"},{"key":"2228_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14712598.8.1.123","volume":"8","author":"Rigopoulos","year":"2008","unstructured":"Rigopoulos D, Korfitis C, Gregoriou S, Katsambas AD (2008) Infliximab in dermatological treatment: beyond psoriasis. Expert Opin Biol Ther 8(1):123\u2013133","journal-title":"Expert Opin Biol Ther"},{"key":"2228_CR27","first-page":"78","volume":"18","author":"Saleem","year":"2008","unstructured":"Saleem K, Azim W (2008) Treatment of nail psoriasis with a modified regimen of steroid injections. J Coll Physicians Surg Pak 18(2):78\u201381","journal-title":"J Coll Physicians Surg Pak"},{"key":"2228_CR28","first-page":"1418","volume":"159","author":"Saraceno","year":"2008","unstructured":"Saraceno R, Bianchi L, Pietroleonardo L (2008) Remission and time of resolution of nail psoriasis: a comparison among antitumor necrosis factor-alpha inhibitors. Br J Dermatol 159(6):1418, P47","journal-title":"Br J Dermatol"},{"key":"2228_CR29","first-page":"355","volume":"68","author":"Scher","year":"2001","unstructured":"Scher RK, Stiller M, Zhu YI (2001) Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 68(5):355\u2013358","journal-title":"Cutis"},{"key":"2228_CR30","unstructured":"Tan AL, Benjamin M, Toumi H et al (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis\u2013a high-resolution MRI and histological study. Rheumatology (Oxford) 46(2):253\u2013256"},{"key":"2228_CR31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2133.2010.09791.x","volume":"163","author":"Tha\u00e7i","year":"2010","unstructured":"Tha\u00e7i D, Ortonne JP, Chimenti S et al (2010) A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol\/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study. Br J Dermatol 163(2):402\u2013411","journal-title":"Br J Dermatol"},{"key":"2228_CR32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","volume":"139","author":"Tosti","year":"1998","unstructured":"Tosti A, Piraccini BM, Cameli N et al (1998) Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 139(4):655\u2013659","journal-title":"Br J Dermatol"},{"key":"2228_CR33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archdermatol.2008.600","volume":"145","author":"Tosti","year":"2009","unstructured":"Tosti A, Ricotti C, Romanelli P et al (2009) Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 145(3):269\u2013271","journal-title":"Arch Dermatol"},{"key":"2228_CR34","first-page":"279","volume":"88","author":"Tzung","year":"2008","unstructured":"Tzung TY, Chen CY, Yang CY et al (2008) Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis. Acta Derm Venereol 88(3):279\u2013280","journal-title":"Acta Derm Venereol"},{"key":"2228_CR35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2009.111856","volume":"69","author":"Van","year":"2010","unstructured":"Van den Bosch F, Manger B, Goupille P et al (2010) Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis 69(2):394\u2013399","journal-title":"Ann Rheum Dis"},{"key":"2228_CR36","doi-asserted-by":"crossref","unstructured":"Williamson L, Dalbeth N, Dockerty JL et al (2004) Extended report: nail disease in psoriatic arthritis \u2013 clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43(6):790\u2013794","DOI":"10.1093\/rheumatology\/keh198"},{"key":"2228_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS et al (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61(2):233\u2013239","journal-title":"Arthritis Rheum"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-011-2228-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-011-2228-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-011-2228-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T18:12:34Z","timestamp":1561399954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-011-2228-4"}},"subtitle":["Pathogenese, Diagnostik, Therapie"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1007\/s00105-011-2228-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}